Cubist Systematic Strategies LLC Purchases Shares of 160,088 Aspen Aerogels, Inc. (NYSE:ASPN)

Cubist Systematic Strategies LLC acquired a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 160,088 shares of the construction company’s stock, valued at approximately $3,818,000. Cubist Systematic Strategies LLC owned about 0.21% of Aspen Aerogels as of its most recent SEC filing.

Several other large investors have also made changes to their positions in ASPN. GSA Capital Partners LLP purchased a new position in shares of Aspen Aerogels in the 1st quarter valued at $1,181,000. Oppenheimer & Co. Inc. purchased a new stake in shares of Aspen Aerogels during the 1st quarter valued at about $388,000. Comerica Bank acquired a new position in Aspen Aerogels during the 1st quarter worth approximately $1,992,000. Vanguard Group Inc. boosted its holdings in Aspen Aerogels by 5.1% in the 1st quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock worth $63,707,000 after acquiring an additional 175,906 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Aspen Aerogels during the first quarter valued at approximately $851,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Aspen Aerogels

In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at $626,610.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 4.30% of the company’s stock.

Aspen Aerogels Stock Up 4.9 %

Shares of NYSE:ASPN opened at $28.54 on Friday. Aspen Aerogels, Inc. has a 1-year low of $6.62 and a 1-year high of $33.15. The company’s fifty day moving average is $25.12 and its two-hundred day moving average is $23.56. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.82 and a current ratio of 3.46. The stock has a market capitalization of $2.17 billion, a price-to-earnings ratio of -64.86 and a beta of 2.16.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.05 by $0.16. The firm had revenue of $117.80 million for the quarter, compared to analysts’ expectations of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. Aspen Aerogels’s revenue was up 144.4% on a year-over-year basis. During the same quarter last year, the company posted ($0.22) earnings per share. Equities analysts anticipate that Aspen Aerogels, Inc. will post 0.21 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. HC Wainwright upped their target price on shares of Aspen Aerogels from $25.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Roth Mkm restated a “buy” rating and set a $36.00 target price on shares of Aspen Aerogels in a research note on Wednesday, August 21st. B. Riley raised Aspen Aerogels to a “strong-buy” rating in a report on Tuesday, June 25th. Barclays assumed coverage on Aspen Aerogels in a research report on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 target price on the stock. Finally, Craig Hallum raised their price target on shares of Aspen Aerogels from $33.00 to $38.00 and gave the stock a “buy” rating in a research report on Friday, June 14th. One research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.70.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.